Current stage?-Stage II - Page 25 of 30 Posts on Medivizor
Navigation Menu

Current stage?-Stage II Posts on Medivizor

Could menopausal symptoms predict prognosis?

Could menopausal symptoms predict prognosis?

Posted by on Oct 27, 2013 in Breast cancer | 0 comments

In a nutshell This present study evaluated the role of menopausal symptoms in the prognosis of breast cancer patients. Some background Menopause is the period in a woman’s life after menstruation stops and the ovaries become inactive, defined as 12 months after a woman's last period. With menopause, the level of female sex hormones such...

Read More

Is active surveillance safe?

Is active surveillance safe?

Posted by on Oct 10, 2013 in Prostate cancer | 0 comments

In a nutshell The study evaluated whether active surveillance (AS) is a safe approach and can prevent over-treatment in patients with prostate cancer.  Some background In the recent years, survival rates for prostate cancer patients have increased due to more advanced screening methods, which allow for early detection and prevention of...

Read More

Can a Mediterranean diet reduce cancer mortality?

Can a Mediterranean diet reduce cancer mortality?

Posted by on Sep 30, 2013 in Prostate cancer | 0 comments

In a nutshell This study investigated whether a Mediterranean diet is linked to better outcomes in men diagnosed with prostate cancer. Some background Dietary changes are thought to affect the development and progression of prostate cancer. However, no study to date has reached conclusive results regarding the effects of diet on mortality from...

Read More

Adherence to trastuzumab therapy

Adherence to trastuzumab therapy

Posted by on Sep 28, 2013 in Breast cancer | 0 comments

In a nutshell This study evaluated the use, effects and adherence of trastuzumab (herceptin) as treatment for patients with breast cancer. Some background Trastuzumab is often prescribed as adjuvant (additional) therapy for human epidermal growth factor receptor-2 positive (HER2+) breast cancer. HER2 is a protein found on the surface of some...

Read More

Removing the lymph nodes, not just the cancer

Removing the lymph nodes, not just the cancer

Posted by on Sep 25, 2013 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effect of lateral pelvic lymph node dissection on survival of rectal cancer patients. Some background Removal of the lymph nodes in the area surrounding lower rectal cancer (lateral pelvic lymph node dissection or LPND) is often performed during surgery to remove the cancer. LPND is usually performed if...

Read More

A new treatment option for breast cancer

A new treatment option for breast cancer

Posted by on Sep 23, 2013 in Breast cancer | 1 comment

In a nutshell This phase II clinical trial examined the safety and efficacy of adding a drug called rh-endostatin (Endostar) to chemotherapy in breast cancer patients. Some background Cancer cells need blood supply in order to grow. As cancer grows, it forms its own blood vessels, a process called angiogenesis. Therefore, anti-angiogenesis...

Read More

Could metformin be used to treat cancer?

Could metformin be used to treat cancer?

Posted by on Sep 22, 2013 in Prostate cancer | 0 comments

In a nutshell This study investigated the relationship between the use of metformin (Glucophage) and prostate cancer mortality. Some background Metformin is a drug commonly used in the management of diabetes. Metformin works by suppressing glucose production in the liver and increasing the body's sensitivity to insulin. Recent studies have...

Read More

Can biology of the cancer predict survival?

Can biology of the cancer predict survival?

Posted by on Sep 21, 2013 in Colorectal cancer | 0 comments

In a nutshell This study investigated whether the biology of the cancer called mucinous histology can be used to predict the outcomes of patients with colorectal cancer. The study also evaluated the association between mucinous adenocarcinoma and microsatellite instability. Some background Mucinous histology (MH) is a microscopic observation of...

Read More

Radiotherapy and tamoxifen can reduce the risk of recurrence in breast cancer patients who underwent conservative surgery

Radiotherapy and tamoxifen can reduce the risk of recurrence in breast cancer patients who underwent conservative surgery

Posted by on Sep 12, 2013 in Breast cancer | 0 comments

In a nutshell This study compared the benefits of radiotherapy and tamoxifen in reducing the risk of local recurrence (return of the cancer close to initial place of origin) in patients with early breast cancer who underwent breast conserving surgery (BCS). Some background Women with early breast cancer usually have tumors that are confined...

Read More